The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathol. (Berl.), vol.114, issue.2, pp.97-109, 2007. ,
French Brain Tumor DataBase: 5-Year Histological Results on 25 756 Cases: FBTDB of Histological Results, Brain Pathol, vol.21, issue.6, pp.633-644, 2004. ,
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States, Neuro-Oncol, vol.14, issue.5, pp.1-49, 2005. ,
Épidémiologie des tumeurs cérébrales primitives, Neurologie.com, issue.4, pp.83-86, 2010. ,
Primary brain tumours in adults, The Lancet, vol.379, issue.9830, pp.1984-1996, 2012. ,
Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period, Neuro-Oncol, vol.13, issue.12, pp.1370-1378, 2000. ,
Tumors of the Brain and Nervous System after Radiotherapy in Childhood, N. Engl. J. Med, vol.319, issue.16, pp.1033-1039, 1988. ,
Cancer stem cells in nervous system tumors, Oncogene, vol.23, issue.43, pp.7267-7273, 2004. ,
Non-Stem Cell Origin for Oligodendroglioma, Cancer Cell, vol.18, issue.6, pp.669-682, 2010. ,
Glioma Stem Cells: A Midterm Exam, Neuron, vol.58, issue.6, pp.832-846, 2008. ,
An Integrated Genomic Analysis of Human Glioblastoma Multiforme, Science, vol.321, issue.5897, pp.1807-1812, 2008. ,
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas, Clin. Cancer Res, vol.15, issue.19, pp.6002-6007, 2009. ,
Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas, Cancer, vol.79, issue.7, pp.1381-1393, 1997. ,
Limitations of stereotactic biopsy in the initial management of gliomas, Neuro-Oncol, vol.3, issue.3, pp.193-200, 2001. ,
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathol. (Berl.), vol.131, issue.6, pp.803-820, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01479018
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma, N. Engl. J. Med, vol.374, issue.14, pp.1344-1355, 2016. ,
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.31, issue.3, pp.344-350, 2013. ,
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.31, issue.3, pp.337-343, 2013. ,
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q nonco-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study, Lancet Lond. Engl, vol.390, issue.10103, pp.1645-1653, 2017. ,
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N. Engl. J. Med, vol.352, issue.10, pp.987-996, 2005. ,
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, Lancet Oncol, vol.10, issue.5, pp.459-466, 2009. ,
MGMT gene silencing and benefit from temozolomide in glioblastoma, N. Engl. J. Med, vol.352, issue.10, pp.997-1003, 2005. ,
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma, N. Engl. J. Med, vol.376, issue.11, p.2017 ,
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group, J. Clin. Oncol, vol.28, issue.11, pp.1963-1972, 2010. ,
Diagnostic différentiel entre récidive tumorale et radionécrose après radiothérapie stéréotaxique d'une métastase cérébrale, Cancer/Radiothérapie, vol.18, issue.2, pp.142-146, 2014. ,
Impact de la TEP à la 18F-DOPA sur la décision thérapeutique en RCP lors du diagnostic différentiel entre radionécrose et récidive de néoplasie cérébrale, Médecine Nucl, vol.38, issue.3, pp.132-133, 2014. ,
The future of high-grade glioma: Where we are and where are we going, Surg. Neurol. Int, vol.6, issue.2, p.9, 2015. ,
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme, J. Clin. Oncol, vol.25, issue.30, pp.4722-4729, 2007. ,
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma, N. Engl. J. Med, vol.370, issue.8, pp.699-708, 2014. ,
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence, Neurology, vol.70, issue.10, pp.779-787, 2008. ,
Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma, Int. J. Radiat. Oncol. Biol. Phys, vol.16, issue.6, pp.1405-1409, 1989. ,
Re-irradiation for recurrent glioblastoma multiforme, Chin. Clin. Oncol, vol.6, issue.4, pp.36-36, 2017. ,
Radiobiologie des doses ablatives en radiothérapie stéréotaxique : mise au point des données récentes, Cancer/Radiothérapie, vol.18, issue.4, pp.264-269, 2014. ,
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline, Pract. Radiat. Oncol, vol.6, issue.4, pp.217-225, 2016. ,
Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.35, issue.3, pp.361-369, 2017. ,
Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme, J. Clin. Oncol, vol.28, issue.24, pp.3838-3843, 2010. ,
Réirradiation cérébrale des tumeurs primitives malignes ou secondaires, Cancer/Radiothérapie, vol.14, issue.6-7, pp.421-437, 2010. ,
Re-irradiation for recurrent high-grade gliomas: a systematic review and analysis of treatment technique with respect to survival and risk of radionecrosis, Neuro-Oncol. Pract, vol.6, issue.2, pp.144-155, 2019. ,
Non-conventional fotemustine schedule as second-line treatment in recurrent malignant gliomas: Survival across disease and treatment subgroup analysis and review of the literature, Mol. Clin. Oncol, 2018. ,
Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control, Cancer Med, vol.2, issue.6, pp.942-949, 2013. ,
Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?, Strahlenther. Onkol. Organ Dtsch. Rontgengesellschaft Al, vol.185, issue.4, pp.235-240, 2009. ,
Re-irradiation in the Brain: Primary Gliomas, Clin. Oncol, vol.30, issue.2, pp.124-136, 2018. ,
Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas, Int. J. Radiat. Oncol. Biol. Phys, vol.45, issue.5, pp.1133-1141, 1999. ,
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO), J. Neurooncol, vol.142, issue.1, pp.59-67, 2019. ,
Radiosurgery in the treatment of malignant gliomas: the University of Florida experience, Neurosurgery, vol.57, issue.3, pp.512-517, 2005. ,
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy, Int. J. Radiat. Oncol, vol.63, issue.2, pp.511-519, 2005. ,
Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma, J. Neurooncol, vol.103, issue.3, pp.683-691, 2011. ,
Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas, J. Neurooncol, vol.111, issue.2, pp.187-194, 2013. ,
Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas, J. Neurooncol, vol.89, issue.2, pp.205-210, 2008. ,
Efficacy and toxicity of CyberKnife re-irradiation and 'dose dense' temozolomide for recurrent gliomas, Acta Neurochir. (Wien), vol.154, issue.2, pp.203-209, 2012. ,
Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option, J. Neurooncol, vol.117, issue.2, pp.337-345, 2014. ,
Patterns of Failure After Concurrent Bevacizumab and Hypofractionated Stereotactic Radiation Therapy for Recurrent High-Grade Glioma, Int. J. Radiat. Oncol, vol.85, issue.3, pp.636-642, 2013. ,
Reirradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas, J. Neurooncol, vol.112, issue.1, pp.133-139, 2013. ,
Gamma knife for glioma: selection factors and survival, Int. J. Radiat. Oncol. Biol. Phys, vol.36, issue.5, pp.1045-1053, 1996. ,
Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.23, issue.34, pp.8863-8869, 2005. ,
Moving Second Courses of Radiotherapy Forward: Early Re-Irradiation After Surgical Resection for Recurrent Gliomas Improves Efficacy With Excellent Tolerability, Neurosurgery, 2018. ,
Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma -the GlioCave study (NOA 17 -ARO 2016/3 -DKTK ROG trial), BMC Cancer, vol.18, issue.1, 2018. ,
A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma, Int. J. Radiat. Oncol. Biol. Phys, vol.43, issue.2, pp.293-298, 1999. ,
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma, BMC Cancer, vol.5, p.55, 2005. ,
Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.28, issue.18, pp.3048-3053, 2010. ,
Hypofractionated stereotactic radiotherapy in the management of recurrent glioma, Int. J. Radiat. Oncol. Biol. Phys, vol.37, issue.2, pp.393-398, 1997. ,
Reirradiation of primary brain tumours: survival, clinical response and prognostic factors, Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol, vol.59, issue.2, pp.127-137, 2001. ,
Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma, Acta Oncol. Stockh. Swed, vol.52, issue.1, pp.147-152, 2013. ,
Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis, Radiother. Oncol, vol.127, issue.1, pp.121-127, 2018. ,
External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiation, Pract. Radiat. Oncol, vol.5, issue.3, pp.143-150, 2015. ,
Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK), Cancer Med, vol.7, issue.5, pp.1742-1749, 2018. ,
Radiolesion versus Recurrence: Bioptic Data in 39 Gliomas After Interstitial, or Combined Interstitial and External Radiation Treatment, Advances in Stereotactic and Functional, pp.291-299, 1984. ,
Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma, J. Neurooncol, vol.81, issue.3, pp.287-294, 2007. ,